Cargando…
Transforming growth factor-β1 and SMAD signalling pathway in the small airways of smokers and patients with COPD: potential role in driving fibrotic type-2 epithelial mesenchymal transition
BACKGROUND: COPD is a common disease characterized by respiratory airflow obstruction. TGF-β1 and SMAD pathway is believed to play a role in COPD pathogenesis by driving epithelial mesenchymal transition (EMT). METHODS: We investigated TGF-β1 signalling and pSmad2/3 and Smad7 activity in resected sm...
Autores principales: | Brake, Samuel James, Lu, Wenying, Chia, Collin, Haug, Greg, Larby, Josie, Hardikar, Ashutosh, Singhera, Gurpreet K., Hackett, Tillie L., Eapen, Mathew Suji, Sohal, Sukhwinder Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331458/ https://www.ncbi.nlm.nih.gov/pubmed/37435075 http://dx.doi.org/10.3389/fimmu.2023.1216506 |
Ejemplares similares
-
SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD – Possible Implications for Interstitial Fibrosis
por: Brake, Samuel James, et al.
Publicado: (2022) -
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension
por: Bhattarai, Prem, et al.
Publicado: (2022) -
Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition
por: Eapen, Mathew Suji, et al.
Publicado: (2021) -
Endothelial-to-mesenchymal transition: a precursor to pulmonary arterial remodelling in patients with idiopathic pulmonary fibrosis
por: Gaikwad, Archana Vijay, et al.
Publicado: (2023) -
Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections
por: Lu, Wenying, et al.
Publicado: (2022)